In this study, two capillary electrophoresis–based ligand binding assays, namely, mobility shift affinity capillary electrophoresis (ms‐ACE) and capillary electrophoresis‐frontal analysis (CE‐FA), were applied to determine binding parameters of human serum albumin toward small drugs under similar experimental conditions. The substances S‐amlodipine (S‐AML), lidocaine (LDC), l‐tryptophan (l‐TRP), carbamazepine (CBZ), ibuprofen (IBU), and R‐verapamil (R‐VPM) were used as the main binding partners. The scope of this comparative study was to estimate and compare both the assays in terms of their primary measure's precision and the reproducibility of the derived binding parameters. The effective mobility could be measured with pooled CV values between 0.55% and 7.6%. The precision of the r values was found in the range between 1.5% and 10%. Both assays were not universally applicable. The CE‐FA assay could successfully be applied to measure the drugs IBU, CBZ, and LDC, and the interaction toward CBZ, S‐AML, l‐TRP, and R‐VPM could be determined using ms‐ACE. The average variabilities of the estimated binding constants were 64% and 67% for CE‐FA and ms‐ACE, respectively.
Analytical-method development based on design of experiment has been applied for optimizing the enantioseparation of amlodipine by chiral capillary electrokinetic chromatography using maltodextrin as the chiral selector. The effect of different factors on the enantioresolution quality was screened. Three separation factors, namely maltodextrin concentration, pH of the background electrolyte and applied voltage were selected as independent variables. The number of experiments was reduced while maximizing the information content using design of experiment. Based on a full-quadratic design that included three variables on three levels, the total design space could be reduced to fifteen factor combinations using a D-optimal algorithm. The aim of the experiment was to find the optimal factor combinations with respect to resolution. The maltodextrin concentration (7.5–10% w/v) demonstrated the strongest effect on the resolution followed by pH (2–4) of the background electrolyte and the applied voltage (15–20 kV). An increase in the maltodextrin concentration was found to result in a greater stereoselectivity, represented by the higher resolution values (Rs ≥ 1.5). The separation conditions in the proposed method were feasible to be adjusted within the applied range with an acceptable resolution.
29 July 2025 in Measurement Science and Technology
A Bayesian inference approach for the quantitative analysis of high-resolution gamma-ray spectra is proposed. The resulting posterior distribution for the sought isotope activities allows to calculate estimates, as well as corresponding uncertainties and credible intervals. The approach is based on a full-spectrum-analysis methodology by utilizing a set of well characterized template spectra for the different isotopes. A statistical model for the analyzed gamma-ray spectra is developed which includes all relevant uncertainty sources such as random fluctuations in the data and the uncertainty of the isotope activities underlying the template spectra. The approach includes a novel correction methodology which accounts for possible deviations between the energy scales of the analyzed spectrum and the template spectra, which is required for a precise analysis of the high-resolution spectra. Furthermore, the approach enables the inclusion of multiple template spectra for a single isotope recorded at different activity levels, which can be advantageous in the presence of a non-linear detector response. Calculation of the posterior distribution is carried out using Markov chain Monte Carlo sampling techniques. Application of the approach is demonstrated using a set of spectra from samples containing different isotope mixtures. A comparison of the activities obtained by the proposed Bayesian analysis with reference values determined by an established peak evaluation method reveals a high agreement with a root mean square error of only 1.2%. The determined activities are shown to be statistically consistent with the reference procedure, which emphasizes the reliability of the uncertainties derived by the proposed methodology. Software to ease the uptake of the proposed methodology is made available.
Liver organoids are emerging tools for precision drug development and toxicity screening. We demonstrate that electromembrane extraction (EME) based on electrophoresis across an oil membrane is suited for segregating selected organoid-derived drug metabolites prior to mass spectrometry (MS)-based measurements. EME, allowed drugs and drug metabolites to be separated from cell medium components (albumin, etc.) that could interfere with subsequent measurements. Multi-well EME (Parallel-EME) holding 100 μL solutions allowed for simple and repeatable monitoring of heroin phase I metabolism kinetics. Organoid Parallel-EME extracts were compatible with ultrahigh-performance liquid chromatography (UHPLC) used to separate the analytes prior to detection. Taken together, liver organoids are well-matched with EME followed by MS-based measurements.